1. High-Dose Statins in Preventing Microvascular Obstruction: “The Devil Lies in the Details”
   Renzo Laborante et al, 2023, The American Journal of Cardiology CrossRef
2. No-reflow phenomenon in the heart and brain
   Robert A. Kloner et al, 2018, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
3. Comparing the Effect of a Preprocedural Loading Dose of Atorvastatin vs. Rosuvastatin on the Prevalence of No-reflow and Low TIMI Flow in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention
   Naser Aslanabadi et al, 2022, Shiraz E-Medical Journal CrossRef
4. Enhanced-Dose Statins for ST-Segment Elevation Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention
   Wenzhong Chen et al, 2022, Disease Markers CrossRef
5. A systematic review and meta-analysis of the effect of high-intensity statin on coronary microvascular dysfunction
   Bihan Huang et al, 2023, BMC Cardiovascular Disorders CrossRef
6. Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management
   Jathinder Kumar et al, 2019, Expert Review of Cardiovascular Therapy CrossRef
7. Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
   Esraa M. Adel et al, 2022, Journal of Clinical Medicine CrossRef
8. Meta-Analysis on the Efficacy of High-Dose Statin Loading Before Percutaneous Coronary Intervention in Reducing No-Reflow Phenomenon in Acute Coronary Syndrome
   Sonia Anayat et al, 2023, The American Journal of Cardiology CrossRef